CORC

在结果中检索

CORC

浏览/检索结果: 共97条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
How public investment fuels innovation: Clues from Government-subsidized Patents 1980-2017 会议论文
作者:  Zhang, Lin;  Peng, Yujie;  Zhao, Wenjing;  Chen, Lixin;  Huang, Ying
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Budget constraint roadside units placement for traffic flows monitoring system with reliability in vehicular networks 会议论文
作者:  Jiang, Peng;  Li, Peng;  Zhang, Tao;  Huang, Weiyi;  He, Heng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
A cloud-based platform for marine oil spill emergency response capability visualization 会议论文
作者:  Huang, Liang;  Peng, Xin;  Zhang, Fan;  Wen, Yuanqiao;  Xiao, Changshi
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Discriminative Regularization with Conditional Generative Adversarial Nets for Semi-Supervised Learning 会议论文
作者:  Xie, Qianqian;  Peng, Min;  Huang, Jimin;  Wang, Bin;  Wang, Hua
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Study on the breakdown characteristics of conductor-plane gap under vegetation fire condition based on the combustion features 会议论文
作者:  Huang, Daochun;  Lu, Wei;  Yao, Tao;  Li, Peng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05
Exploiting sociality for collaborative message dissemination in VANETs 会议论文
作者:  Huang, Weiyi;  Li, Peng;  Zhang, Tao;  Jin, Yu;  He, Heng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace